AXGT - Axovant Gene Therapies Ltd.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
1.0800
-0.0800 (-6.90%)
At close: 4:00PM EDT

1.1000 +0.02 (1.85%)
After hours: 4:04PM EDT

Stock chart is not supported by your current browser
Previous Close1.1600
Open1.1500
Bid1.0700 x 800
Ask1.1000 x 1000
Day's Range1.0600 - 1.1500
52 Week Range0.9300 - 2.4500
Volume832,259
Avg. Volume2,446,304
Market Cap196.818M
Beta (3Y Monthly)2.08
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Imagine Owning Axovant Gene Therapies (NASDAQ:AXGT) And Trying To Stomach The 91% Share Price Drop
    Simply Wall St.2 hours ago

    Imagine Owning Axovant Gene Therapies (NASDAQ:AXGT) And Trying To Stomach The 91% Share Price Drop

    Axovant Gene Therapies Ltd. (NASDAQ:AXGT) shareholders should be happy to see the share price up 19% in the last quarter. But only the myopic could ignore the astounding decline over three years. The share price has sunk l...

  • Axovant (AXGT) Upgraded to Buy: What Does It Mean for the Stock?
    Zacks15 days ago

    Axovant (AXGT) Upgraded to Buy: What Does It Mean for the Stock?

    Axovant (AXGT) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

  • Benzinga20 days ago

    The Daily Biotech Pulse: Merrimack Pulls The Plug On Early-Stage Trial, Legal Headache For Novartis-Amgen Migraine Partnership

    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on April 4) AEterna Zentaris Inc. (NASDAQ: AEZS ) GALAPAGOS NV/S ...

  • Markit23 days ago

    See what the IHS Markit Score report has to say about Axovant Sciences Ltd.

    Axovant Sciences Ltd NASDAQ/NGS:AXGTView full report here! Summary * Bearish sentiment is low Bearish sentimentShort interest | PositiveShort interest is low for AXGT with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Money flowETF/Index ownership | NeutralETF activity is neutral. Over the last one-month, outflows of investor capital in ETFs holding AXGT totaled $214 million. Economic sentimentPMI by IHS Markit | NeutralAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here's Why Axovant Gene Therapies Dropped as Much as 16.6% Today
    Motley Foollast month

    Here's Why Axovant Gene Therapies Dropped as Much as 16.6% Today

    The biopharma is wisely taking advantage of its lofty stock price to raise capital through a share offering.

  • Benzingalast month

    Axovant Shares Surge On Positive Results For Parkinson's, Tay-Sachs Gene Therapies

    Smaller gene therapy biotechs are taking the spotlight given the M&A interest surrounding them. One such gene therapy company saw its shares rallying by more than 30 percent Monday following the release ...

  • Here's Why Axovant Gene Therapies Rocketed Higher Today
    Motley Foollast month

    Here's Why Axovant Gene Therapies Rocketed Higher Today

    Investors are excited about new clinical results suggesting the small-cap biopharma is on to something big.

  • Have Insiders Been Buying Axovant Sciences Ltd. (NASDAQ:AXGT) Shares This Year?
    Simply Wall St.2 months ago

    Have Insiders Been Buying Axovant Sciences Ltd. (NASDAQ:AXGT) Shares This Year?

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! We often see insiders buying up shares in companies thatRead More...